Reported Q: Q1 2025 Rev YoY: N/A EPS YoY: N/A Move: -6.67%
The Marquie Group Inc
TMGI
$0.0700 -6.67%
Exchange OTC Sector Communication Services Industry Broadcasting
Q1 2025
Published: Oct 21, 2024

Company Status Snapshot

Fast view of the latest quarter outcome for TMGI

Reported

Report Date

Oct 21, 2024

Quarter Q1 2025

Revenue

N/A

YoY: N/A

EPS

N/A

YoY: N/A

Market Move

-6.67%

Previous quarter: Q4 2024

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Net income of -204.94K
  • "N/A" - N/A
TMGI
Company TMGI

Executive Summary

The QQ1 2025 results for The Marquie Group Inc (TMGI) depict a financially stressed quarter with no reported revenue and a net loss of $204,944. The operating picture is dominated by a modest operating expense base of $60,640 combined with a sizable interest expense of $107,072, producing an EBITDA of โˆ’$97,779 and an operating loss of โˆ’$60,640. The quarterโ€™s profitability metrics point to a finance-heavy structure rather than a cash generation story, underscored by a negative net income and a lack of reported revenue in the period.

Liquidity and balance-sheet health raise red flags. The company reports total current liabilities of $6.2355 million against total current assets of only $0.642 thousand, yielding an exceptionally weak current ratio (~0.0001) and a cash/quick ratio of 0, signaling material short-term liquidity risk. Net debt stands at $3.5376 million, while total stockholdersโ€™ equity sits at a nominal $11,492 with retained earnings deeply negative at โˆ’$15.068 million. Free cash flow for the quarter is negative at โˆ’$546, underscoring limited cash generation while financing activity offsets it modestly with a $546 inflow.

With no formal forward guidance disclosed in the filing and a large, announced long-term investment line of $6.2 million, the investment thesis rests on optionality: potential monetization or realization of value from non-core assets and any future revenue ramp from core radio/online platforms or the health/beauty product pipeline. Absent clear revenue visibility, investors face elevated downside risk and should focus on liquidity development, debt renegotiation prospects, and any incremental disclosures around revenue-generating activities or strategic asset reallocations.

Key Performance Indicators

Operating Income
Increasing
-60.64K
QoQ: 65.75% | YoY: 21.80%
Net Income
Decreasing
-204.94K
QoQ: -375.04% | YoY: -158.04%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q3 2025 0.00 0.00 +0.0% View
Q2 2025 0.00 0.00 +0.0% View
Q1 2025 0.00 0.00 +0.0% View
Q4 2024 0.00 0.00 +0.0% View
Q3 2024 0.00 0.00 +0.0% View